Argonaut Therapeutics Presents at BioTrinity 2022 Conference
Oxford, UK, 26 April 2022 – Argonaut Therapeutics, a leading developer of novel cancer agents,…
- All
- Press releases
- Uncategorized
Argonaut Therapeutics Announces Appointment of New Board Director Dr Chan Hee Park of JW Pharmaceutical Corporation
Oxford, UK, 21 January 2021 – Argonaut Therapeutics, a leading developer of novel cancer agents,…
Argonaut Therapeutics Announces Appointment of New Board Director Nick Dixon-Clegg OSI
Oxford, UK, 1 August 2020 – Argonaut Therapeutics, a leading developer of novel cancer agents,…
Argonaut Therapeutics Announces Successful Completion of Financing Round
Oxford, UK, March 2019 – Argonaut Therapeutics, a leading developer of novel cancer therapies, announced…